Must we Treat Neuromyelitis Optica in Patients with Myasthenia Gravis More Aggressively? ? A Case Report

Coexistence of neuromyelitisoptica (NMO) and myasthenia gravis (MG) has only rarely been documented. The outcome in these patients, despite all therapeutic interventions, is usually very poor.The aim of our study was to present a case and a short review of literature in order to encourage the neurologists to rethink about the treatment of these patients.We are reporting a case of 48-year old Caucasian woman with MG and the NMO that was treated with high doses of methylprednisolone and underwent plasmaferesis at her last in hospital stay but ended in spastic tetra paresis, bedridden, incontinent and blind. The course of NMO in patients with MG is quite severe with common relapses and poor outcome. Only by summing all our experiences we can bring out a good strategy for their treatment.